Modern management of malignant hypercalcemia

American Journal of Hospice and Palliative Medicine

Volumn 28, Issue 7, 2011, Pages 515-517

  LeGrand, Susan B ^a,b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

bisphosphonates; gallium nitrate; hypercalcemia; palliative care

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; CALCITONIN; GALLIUM; GALLIUM NITRATE; IMIDAZOLE DERIVATIVE; PAMIDRONIC ACID; PARATHYROID HORMONE RELATED PROTEIN; ZOLEDRONIC ACID;

CLINICAL PROTOCOL; FLUID THERAPY; HUMAN; HYPERCALCEMIA; METABOLISM; NEOPLASM; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; REVIEW;

BONE DENSITY CONSERVATION AGENTS; CALCITONIN; CLINICAL PROTOCOLS; DIPHOSPHONATES; FLUID THERAPY; GALLIUM; HUMANS; HYPERCALCEMIA; IMIDAZOLES; NEOPLASMS; PALLIATIVE CARE; PARATHYROID HORMONE-RELATED PROTEIN;

EID: 82555184966     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909111414164     Document Type: Review

References (20)

1. Fojo ATCancer: Principles and Practice of Oncology. 8th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2008:2451-2453.DeVita VTLawrence TSRosenbery SA, ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2008:2451-2453.
2. Besarb A,Caro JF.Mechanisms of hypercalcemia in malignancy.Cancer. 1978;41 (6): 2276-228.
3. Potts John T.Diseases of the parathyroid gland and other hyper- and hypocalcemic disorders.Harrison's Principles of Internal Medicine.:17e.
4. Stewart AF.Clinical practice: hypercalcemia associated with cancer.N Engl J Med. 2005;352 (4): 373-379.
5. de Wit S,Cleton EJ.Hypercalcemia in patients with breast cancer: a survival study.J Cancer Res Clin Oncol. 1994;120 (10): 610-614.
6. Ralston SH,Gallacher SJ,Patel U,Campbell J,Boyle IT.Cancer-associated hypercalcemia: morbidity and mortality.Ann Internal Med. 1990;112 (7): 499-504.
7. Penel N,Dewas S,Doutrelant P,Slisant S,Yazganpanah Y,Adenis A.Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysis.Support Care Cancer. 2008;16 (4): 387-392.
8. Major P,Lortholary A,Hon J, et al.Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized controlled clinical trials.J Clin Oncol. 2001;19 (2): 558-576.
9. Leyland-Jones B.Treatment of cancer-related hypercalcemia: the role of gallium nitrate.Semin Oncol. 2003;30 (2 suppl 5): 13-19.
10. Cvitkovic F,Armand JP,Tubiana-Hulin M,Rossi JF,Warrell RP.Randomized, double blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.Cancer J. 2006;12 (1): 47-53.
11. Gurney H,Grill V,Martin TJ.Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia.Lancet. 1993;341 (8861): 1611-1613.
12. Walls J,Ratcliffe WA,Howell A,Bundred NJ.Response to intravenous bisphosphonates in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.Br J Cancer. 1994;70 (1): 169-172.
13. Leyland-Jones B.Pharmokinetics and therapeutic index of gallium nitrate.Semin Oncol. 1991;18 (4): 16-20.
14. Truong BU,deB Edwardes MD,Papavasiliou V,Goltzman D,Kremer R.Parathyroid hormone -related peptide and survival of patient with cancer and hypercalcemia.Am J Med. 2003;115 (2): 115-121.
15. LeGrand SB,Leskuski D,Zama I.Narrative review: furosemide for hypercalcemia: an unproven yet common practice.Ann Internal Med. 2008;149 (4): 259-263.
16. Body JJ.Current and future directions in medical therapy: hypercalcemia.Cancer. 2000;88 (12 suppl): 3054-3058.
17. Mundy GR,Guise TA.Hypercalcemia of malignancy.Am J Med. 1997;103 (2): 134-145.
18. Markowitz GS,Fine PL,Stack JI, et al.Toxic acute tubular necrosis following treatment with zoledronate (Zometa).Kidney Int. 2003;64 (1): 281-289.
19. Chang JT,Green L,Beitz J.Renal failure with the use of zoledronic acid.N Engl J Med. 2003;349 (17): 1676-1679.
20. Machado CE,Flombaum CD.Safety of pamidronate in patients with renal failure and hypercalcemia.Clin Nephrol. 1996;45 (3): 175-179.